Entrada Therapeutics, Inc.

Q3 2025 13F Holders

Symbol
TRDA
CUSIP
29384C108
Type
Equity
Class
COM
Num filers
116
Total reported value, excl. options
$169M
Manager Report Date Value ($000) Shares